SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-033947
Filing Date
2024-03-20
Accepted
2024-03-20 07:30:10
Documents
13
Period of Report
2024-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vera-20240320.htm   iXBRL 8-K 47177
2 EX-99.1 vera-ex99_1.htm EX-99.1 106902
3 GRAPHIC img47757703_0.jpg GRAPHIC 8863
  Complete submission text file 0000950170-24-033947.txt   294573

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20240320.xsd EX-101.SCH 26982
16 EXTRACTED XBRL INSTANCE DOCUMENT vera-20240320_htm.xml XML 4896
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 24766286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)